Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

VTAK - Catheter Precision Inc.


Close
0.591
-0.769   -130.118%

Share volume: 2,725,939
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$1.36
-0.77
-56.54%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
21%
Profitability 8%
Dept financing 15%
Liquidity 43%
Performance 30%
Company vs Stock growth
vs
Performance
5 Days
-27.66%
1 Month
-20.47%
3 Months
-72.96%
6 Months
-72.19%
1 Year
-73.87%
2 Year
-81.43%
Key data
Stock price
$0.59
P/E Ratio 
-0.13
DAY RANGE
$0.57 - $1.31
EPS 
-$14.25
52 WEEK RANGE
$1.25 - $8.40
52 WEEK CHANGE
-$0.75
MARKET CAP 
1.345 M
YIELD 
N/A
SHARES OUTSTANDING 
988.752 K
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$81,715
AVERAGE 30 VOLUME 
$102,493
Company detail
CEO:
Region: US
Website: https://www.ramed.com/
Employees: 74
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

advanced excimer laser-based vascular and dermatological therapies we are a commercial-stage medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. we believe our products enhance patients’ quality of life by restoring blood-flow in arteries and clearing chronic skin conditions. we currently manufacture and market two lines of products: dabra catheter and laser is cleared by the u.s. fda as a tool for the minimally invasive endovascular treatment of vascular blockages resulting from lower extremity vascular disease, which includes peripheral artery disease (pad), which commonly occurs in the legs. pharos excimer laser pharos is designed for use in the treatment of inflammatory skin conditions and is fda cleared as a tool used in the treatment of psoriasis, atopic dermatitis, and leukoderma. our goal is to become the leading medical device company marketing excimer lasers as tools for the treatment of

Recent news